LivaNova (LIVN) Intangibles (2015 - 2026)
LivaNova (LIVN) reported Intangibles of $224.6 million for Q1 2026, down 5.09% on a YoY basis from $236.6 million in Q1 2025, and down 2.35% sequentially from $230.0 million in Q4 2025.
LivaNova (LIVN) Intangibles (2015 - 2026) Analysis & Trends
LivaNova (LIVN) has 12 years of Intangibles data on file, last reported at $224.6 million in Q1 2026.
- For the quarter ending Q1 2026, Intangibles fell 5.09% year-over-year to $224.6 million; the trailing twelve-month figure through Mar 2026 stood at $224.6 million (down 5.09% YoY), and the FY2025 full-year result was $230.0 million, down 3.09% from the prior year.
- Intangibles slipped to $224.6 million in Q1 2026, from $230.0 million in the prior quarter.
- In the past five years, Intangibles ranged from a high of $390.5 million in Q1 2022 to a low of $224.6 million in Q1 2026.
- A 5-year average of $293.9 million and a median of $253.9 million in 2024 frame the typical range for Intangibles.
- Across the five-year window, Intangibles slumped 30.56% in 2024 and decreased 3.09% in 2025, its largest moves.
- Tracing LIVN's Intangibles over 5 years: stood at $368.6 million in 2022, then declined by 29.14% to $261.2 million in 2023, then slipped by 9.14% to $237.3 million in 2024, then slipped by 3.09% to $230.0 million in 2025, then dropped by 2.35% to $224.6 million in 2026.
- Business Quant data shows LIVN's Intangibles at $224.6 million in Q1 2026, $230.0 million in Q4 2025, and $234.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 17.88 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 5.52 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 10.15 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 7.06 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.23 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 62.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 3.14 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 1.91 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 882.00 Mn |
| 10 | LivaNova | 4.30 Bn | 3.76 Bn | 243.75 Mn | 224.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 224.56 Mn |
| Dec 31, 2025 | 229.96 Mn |
| Sep 30, 2025 | 234.53 Mn |
| Jun 30, 2025 | 239.14 Mn |
| Mar 31, 2025 | 236.59 Mn |
| Dec 31, 2024 | 237.29 Mn |
| Sep 30, 2024 | 248.55 Mn |
| Jun 30, 2024 | 248.20 Mn |
| Mar 31, 2024 | 253.93 Mn |
| Dec 31, 2023 | 261.18 Mn |
| Sep 30, 2023 | 347.67 Mn |
| Jun 30, 2023 | 357.42 Mn |
| Mar 31, 2023 | 364.06 Mn |
| Dec 31, 2022 | 368.56 Mn |
| Sep 30, 2022 | 365.03 Mn |
| Jun 30, 2022 | 389.38 Mn |
| Mar 31, 2022 | 390.46 Mn |
| Dec 31, 2021 | 399.68 Mn |
| Sep 30, 2021 | 408.95 Mn |
| Jun 30, 2021 | 419.18 Mn |